ArticleFrontiers in oncology2020

Pretreatment Neutrophil-to-Lymphocyte Ratio (NLR) May Predict the Outcomes of Advanced Non-small-cell Lung Cancer (NSCLC) Patients Treated With Immune Checkpoint Inhibitors (ICIs).

Ye Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.